Polypharmacology by Design: Prioritizing Plant-Derived Compounds Across Inflammation, Oxidative Stress, Metabolic Dysfunction, and Immune Modulation
International Journal of Pharmaceutical And Phytopharmacological Research · 2025 · 15 (3) · 41-50
DOI: 10.51847/5zczeodwl4 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical And Phytopharmacological Research, 2025. Verfasst von Rafael Mendoza und 2 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mendoza, R., Cruz, I., & Lopez, C. (2025). Polypharmacology by Design: Prioritizing Plant-Derived Compounds Across Inflammation, Oxidative Stress, Metabolic Dysfunction, and Immune Modulation. International Journal of Pharmaceutical And Phytopharmacological Research, 15(3), 41-50. https://doi.org/10.51847/5zczeodwl4
Vancouver
Mendoza R, Cruz I, Lopez C. Polypharmacology by Design: Prioritizing Plant-Derived Compounds Across Inflammation, Oxidative Stress, Metabolic Dysfunction, and Immune Modulation. International Journal of Pharmaceutical And Phytopharmacological Research. 2025;15(3):41-50. doi:10.51847/5zczeodwl4
BibTeX
@article{Mendoza2025,
author = {Mendoza, Rafael and Cruz, Isabela and Lopez, Carlos},
title = {Polypharmacology by Design: Prioritizing Plant-Derived Compounds Across Inflammation, Oxidative Stress, Metabolic Dysfunction, and Immune Modulation},
journal = {International Journal of Pharmaceutical And Phytopharmacological Research},
year = {2025},
volume = {15},
number = {3},
pages = {41--50},
doi = {10.51847/5zczeodwl4}
}
EUVIMED